FERTIN PHARMA

Serial Number 98326058
730

Registration Progress

Application Filed
Dec 21, 2023
Under Examination
Nov 26, 2024
Approved for Publication
Oct 15, 2024
Published for Opposition
Oct 15, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 1 Granted
Due: Nov 26, 2025 132 days

Trademark Image

FERTIN PHARMA

Basic Information

Serial Number
98326058
Filing Date
December 21, 2023
Published for Opposition
October 15, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
730
Status Date
Jan 13, 2025
Application
Pending
Classes
005 040 042

Rights Holder

Fertin Pharma A/S

16
Address
Dandyvej 19
Vejle 7100
DK

Ownership History

Fertin Pharma A/S

Original Applicant
16
Vejle DK

Fertin Pharma A/S

Owner at Publication
16
Vejle DK

Legal Representation

Attorney
Tamar Niv Bessinger

USPTO Deadlines

Next Deadline
132 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
November 26, 2025
Extension Available
Until November 26, 2025

Application History

22 events
Date Code Type Description Documents
Mar 4, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 14, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 13, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 13, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 26, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 15, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 15, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 25, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 5, 2024 ERRR O ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Loading...
Sep 4, 2024 AMPX O PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Loading...
Sep 4, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 21, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 21, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 21, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 24, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 24, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 24, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 23, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 3, 2024 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Apr 2, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 2, 2024 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Dec 21, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, smoking cessation preparations, analgesic preparations, sleep aid- preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; pharmaceutical preparations, namely, smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders in chewable form, in gum form, in lozenge form, and in pouch powder form; aerosolized and inhaled therapeutics and pharmaceuticals, namely, smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti- pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; pharmaceutical preparations for inhalation, namely, smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; drug delivery agents in the form of fast liquefiable tablets, compressed gum, extruded gum, lozenges, pouch powder, dissolvable films, coatings for tablets, and transdermal patches that facilitate the delivery of pharmaceutical preparations, namely, smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; vitamins and dietary supplements; dietetic foodstuffs adapted for medical purposes; nicotine gum for use as an aid to stop smoking; medicated chewing gum as a drug delivery agent to facilitate the delivery of pharmaceutical preparations; dietetic preparations for medical use; herbal extracts for medical purposes; herbal teas for medicinal purposes
Class 040
Custom manufacture of pharmaceuticals and nutraceuticals; consultancy regarding the custom manufacture of pharmaceuticals and nutraceuticals; custom manufacture of pharmaceuticals, namely, formulation of pharmaceutical preparations for treatment of a wide variety of conditions in chewable form, in gum form, in lozenge form, and in pouch powder form; custom manufacture of pharmaceuticals, namely, formulation of inhaled therapeutics; custom manufacture of pharmaceuticals, namely, formulation of pharmaceuticals and well-being products for oral and intra-oral delivery systems; research, and development of pharmaceuticals and well-being products for oral and intra-oral delivery systems; custom manufacture of pharmaceuticals, namely, formulation of pharmaceuticals for smoking cessation; provision of advice, information and consultancy in relation to the aforesaid services
Class 042
Scientific, medical and technological services and research and design relating thereto namely, research and development of technology in the field of smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; industrial analysis and industrial research services in the field of pharmaceutical research and development services; research, and development of pharmaceutical preparations for treatment of a wide variety of conditions in chewable form, in gum form, in lozenge form, and in pouch powder form; research and development of inhaled therapeutics; research, and development of pharmaceuticals and well-being products for oral and intra-oral delivery systems; research and development of pharmaceuticals for smoking cessation; provision of advice, information and consultancy in relation to the aforesaid service

Additional Information

Design Mark
The mark consists of The stylized wording "FERTIN PHARMA" with an outline of an oblong oval encompasses the letters "F" and "E" in the word "FERTIN", and the letter "P" in "PHARMA", italicized, is placed directly under the letter "R" in "FERTIN".
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005 040 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMA"